---
figid: PMC9554177__12264_2022_878_Fig4_HTML
pmcid: PMC9554177
image_filename: 12264_2022_878_Fig4_HTML.jpg
figure_link: /pmc/articles/PMC9554177/figure/Fig4/
number: Fig. 4
figure_title: ''
caption: RAGE-activation-dependent signaling is present in numerous disorders of the
  nervous system. The diseases noted in the text are divided into two tables based
  on the location of the pathological changes. The RAGE ligands listed are assigned
  to specific conditions. Pro-inflammatory RAGE ligands such as S100A, S100B, and
  HMGB1 participate in the development of disease by binding to RAGE. Although in
  some circumstances, low and slightly raised levels of a given molecule may have
  a neuroprotective, pro-regenerative effect on the neuronal system, excessive levels
  lead to pathological pathway activation. A Chemo-induced neuropathy is an exemplary
  peripheral nervous system (PNS) disease. The figure presents multiple mechanisms
  that lead to neurodegeneration. Paclitaxel is an anti-cancer drug that causes an
  increased expression of RAGE in the DRG (1). At the same time, it increases the
  expression of HMGB1 in macrophages (2). Oxaliplatin has a similar effect on non-macrophage
  cells (3), as it increases the production of HMGB1. Interestingly, recent research
  provides data suggesting that papaverine treatment increases neuronal recovery,
  which helps in alleviating neuropathic pain (4). B Multiple sclerosis is an exemplary
  CNS neurodegenerative disease. Microglial RAGE binds to S100A8/A9, activating NF-ÎºB
  via JNK/ERK pathway, which then increases the production of inflammatory cytokines.
  Moreover, due to metabolic changes, astrocytes produce excessive AGEs, which also
  bind to RAGE on microglia and macrophages within the lesion. Subsequently, this
  leads to demyelination along with inflammation, to further neurodegeneration and
  health decline.
article_title: Role of RAGE in the Pathogenesis of Neurological Disorders.
citation: Judyta Juranek, et al. Neurosci Bull. 2022 Oct;38(10):1248-1262.
year: '2022'

doi: 10.1007/s12264-022-00878-x
journal_title: Neuroscience Bulletin
journal_nlm_ta: Neurosci Bull
publisher_name: Springer Nature Singapore

keywords:
- Receptor for advanced glycation end-products
- Nervous system
- Neurological disorders
- Sensorimotor disorders

---
